Nicolas Beranger

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Management and follow-up of pregnancy-onset thrombotic thrombocytopenic purpura: the French experience.

Management and follow-up of pregnancy-onset thrombotic thrombocytopenic purpura: the French experience.

Journal: Blood advances

Published: October 19, 2023

High sFlt-1 (Soluble fms-Like Tyrosine Kinase 1)/PlGF (Placental Growth Factor) Ratio in Pregnancy-Onset Thrombotic Thrombocytopenic Purpura.

High sFlt-1 (Soluble fms-Like Tyrosine Kinase 1)/PlGF (Placental Growth Factor) Ratio in Pregnancy-Onset Thrombotic Thrombocytopenic Purpura.

Journal: Hypertension (Dallas, Tex. : 1979)

Published: May 12, 2023

TTP: From empiricism for an enigmatic disease to targeted molecular therapies.

TTP: From empiricism for an enigmatic disease to targeted molecular therapies.

Journal: British journal of haematology

Published: September 21, 2021

Lupus anticoagulant and ischemic strokes: about two case reports

Lupus anticoagulant and ischemic strokes: about two case reports

Journal: Annales de biologie clinique

Published: August 24, 2021

Imbalance of von Willebrand factor and ADAMTS13 axis is rather a biomarker of strong inflammation and endothelial damage than a cause of thrombotic process in critically ill COVID-19 patients.

Imbalance of von Willebrand factor and ADAMTS13 axis is rather a biomarker of strong inflammation and endothelial damage than a cause of thrombotic process in critically ill COVID-19 patients.

Journal: Journal of thrombosis and haemostasis : JTH

Published: May 20, 2021

Acquired hemophilia A: clinical and biological characteristics and therapeutic management of a series of eight patients hospitalized in Lariboisière and Saint-Louis hospitals

Acquired hemophilia A: clinical and biological characteristics and therapeutic management of a series of eight patients hospitalized in Lariboisière and Saint-Louis hospitals

Journal: Annales de biologie clinique

Published: February 24, 2021

von Willebrand factor/ADAMTS13 axis and venous thromboembolism in moderate-to-severe COVID-19 patients.

von Willebrand factor/ADAMTS13 axis and venous thromboembolism in moderate-to-severe COVID-19 patients.

Journal: British journal of haematology

Published: August 11, 2020

Diagnosis and follow-up of thrombotic thrombocytopenic purpura with an automated chemiluminescent ADAMTS13 activity immunoassay.

Diagnosis and follow-up of thrombotic thrombocytopenic purpura with an automated chemiluminescent ADAMTS13 activity immunoassay.

Journal: Research and practice in thrombosis and haemostasis

Published: August 05, 2020

Loss of von Willebrand factor high-molecular-weight multimers at acute phase is associated with detectable anti-ADAMTS13 IgG and neurological symptoms in acquired thrombotic thrombocytopenic purpura.

Loss of von Willebrand factor high-molecular-weight multimers at acute phase is associated with detectable anti-ADAMTS13 IgG and neurological symptoms in acquired thrombotic thrombocytopenic purpura.

Journal: Thrombosis research

Published: March 17, 2019

Multifactorial hypercoagulable state associated with a thrombotic phenotype in phosphomannomutase-2 congenital disorder of glycosylation (PMM2-CDG): Case report and brief review of the literature.

Multifactorial hypercoagulable state associated with a thrombotic phenotype in phosphomannomutase-2 congenital disorder of glycosylation (PMM2-CDG): Case report and brief review of the literature.

Journal: Thrombosis research

Published: December 21, 2018

BNP response during Berlin Heart® support in child: a case report.

BNP response during Berlin Heart® support in child: a case report.

Journal: Annales de biologie clinique

Published: September 30, 2017

Showing 1-11 of 11

Last Updated: 09/26/2026